Alaunos Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Name: Alaunos Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: Alaunos Therapeutics Inc
Rating: 1.49116675
Author: Trendlyne DVM scores

about

Alaunos Therapeutics Inc is a clinical-stage cellular immuno-oncology company dedicated to the treatment of solid tumors through adoptive TCR-T cell therapy. It strikes cancer at its core by engineering cell therapies that target Neoantigens arising ...

2.85 -0.02 (-0.70%)

54.03% Fall from 52W High

19,976

XNAS Volume

XNAS 31 Jul, 2025 4:00 PM (EDT)

Not Eligible

Expensive Valuation

5.7 / 100

Technically Neutral

54.0 / 100

No estimates available

Alaunos Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Alaunos Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Alaunos Therapeutics Inc is a clinical-stage cellular immuno-oncology company dedicated to the treatment of solid tumors through adoptive TCR-T cell therapy. It strikes cancer at its core by engineering cell therapies that target Neoantigens arising ...

54.03% Fall from 52W High

SWOT Analysis

Alaunos Therapeutics Inc Live Price Chart